Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils

There is compelling evidence for the role of the leucine-rich repeat kinase 2 (LRRK2) and in particular its kinase function in Parkinson's disease. Orally bioavailable, brain penetrant and potent LRRK2 kinase inhibitors are in the later stages of clinical development. Here, we describe a facile...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Ying, Howden, Andrew J.M., Sarhan, Adil R., Lis, Pawel, Ito, Genta, Martinez, Terina N., Brockmann, Kathrin, Gasser, Thomas, Alessi, Dario R., Sammler, Esther M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748842/
https://www.ncbi.nlm.nih.gov/pubmed/29127255
http://dx.doi.org/10.1042/BCJ20170803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748842/
https://www.ncbi.nlm.nih.gov/pubmed/29127255
http://dx.doi.org/10.1042/BCJ20170803

Ejemplares similares